Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (310)	10/29/2001 1:32:20 AM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 724

<<I believe that orders are about to go through the roof, but increasing capacity to meet demand seems to have been a weakness in the past.>> After four flat years they started 2001 with good growth rate for first 2Q. Based on the end of 2Q backlog orders seams that 3Q and 4Q will continue trend. However, this is usually period when competitors figure out that they are doing something wrong. So, 2002 will be important for sustain growth rate (with new and improved products, and market expansion). I think based on this value current market capitalization is projected. Seams that street is favoring under-valuation model, not opposite. Is luck of capacity increase potential problems, or just luck of the self-confidence and early preparation for higher demand? Miljenko